MedPath

Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms

Phase 4
Conditions
Dry Eye Syndromes
Interventions
Drug: Altaire Gel forming solution
Registration Number
NCT01382810
Lead Sponsor
Innovative Medical
Brief Summary

The purpose of this study is to evaluate and compare the effects of Altaire Gel forming solution and Refresh Tears in mild-moderate dry eye patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients 18 years or older.
  • Males or females.
  • Patient reported dry eye symptoms (episodic, annoying, activity limiting).
  • Physician assessment of mild-moderate dry eye.
  • Patient willing to instill drops TID and complete entire length of protocol.
  • TBUT _< 10 seconds.
  • At least Grade 6 Corneal Staining.
Exclusion Criteria
  • Current topical cyclosporine use (Restasis)
  • Current Refresh use.
  • Refractive surgery within the last 6 months.
  • Oral or topical corticosteroid use.
  • Severe dry eye patients by physician assessment.
  • Current active blepharitis.
  • Oral doxycycline use.
  • Oral antihistamine use.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Altaire Gel forming solutionAltaire Gel forming solution-
Refresh TearsRefresh Tears-
Primary Outcome Measures
NameTimeMethod
TBUT2 months

Test performed that measures how long the tears take to break up

Conjunctival and Corneal staining2 months

Dye that will be placed inside the eye to evaluate the surface of the ey

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Koch Eye Associates

🇺🇸

Warwick, Rhode Island, United States

Jackson Eye, SC

🇺🇸

Lake Villa, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath